UM Ventures technology license granted

University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore and the University of Maryland, College Park, and Baltimore-based SilcsBio LLC, a supplier of computer-directed drug discovery software and services, announced that SilcsBio has obtained exclusive rights to a technology licensed from UMB.

Leave a Reply

Your email address will not be published. Required fields are marked *